Showing results (391-400 of 463) with videos related to

Sort By:
Pageof 47
Cancers|April 3, 2020
Calcium Release-Activated Calcium (CRAC) Channel Inhibition Suppresses Pancreatic Ductal Adenocarcinoma Cell Proliferation and Patient-Derived Tumor GrowthHusain Yar Khan, Gabriel B Mpilla, Rachel Sexton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2010
Pain and emotional well-being outcomes in Southwest Oncology Group-directed intergroup trial S0205: a phase III study comparing gemcitabine plus cetuximab versus gemcitabine as first-line therapy in patients with advanced pancreas cancerCarol M Moinpour, Nancy L Vaught, Bryan Goldman, et al.
International Journal of Nanomedicine|February 19, 2019
99mTc-radiolabeled composites enabling in vivo imaging of arterial dispersal and retention of microspheres in the vascular network of rabbit lungs, liver, and liver tumorsRoss W Stephens, Gregory D Tredwell, Karen J Knox, et al.
NPJ Precision Oncology|June 15, 2026
Optimization of first-line treatment selection in advanced pancreatic adenocarcinoma using artificial intelligenceSebastian Cole, Paul Campitelli, Brian Grieb, et al.
World Journal of Gastroenterology|March 6, 2015
Appropriateness of systemic treatments in unresectable metastatic well-differentiated pancreatic neuroendocrine tumorsJonathan R Strosberg, George A Fisher, Al B Benson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2009
Consensus report of the national cancer institute clinical trials planning meeting on pancreas cancer treatmentPhilip A Philip, Margaret Mooney, Deborah Jaffe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 22, 2016
Ramucirumab combined with FOLFOX as front-line therapy for advanced esophageal, gastroesophageal junction, or gastric adenocarcinoma: a randomized, double-blind, multicenter Phase II trialH H Yoon, J C Bendell, F S Braiteh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2019
Phase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma: SWOG S1313Ramesh K Ramanathan, Shannon L McDonough, Philip A Philip, et al.
Complementary Therapies in Clinical Practice|April 9, 2008
Antibacterial activity of honey against community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)Yasunori Maeda, Anne Loughrey, J A Philip Earle, et al.
Oncogene|May 26, 2022
Molecular profiling of signet-ring-cell carcinoma (SRCC) from the stomach and colon reveals potential new therapeutic targetsAlberto Puccini, Kelsey Poorman, Fabio Catalano, et al.
Pageof 47